Refractive Error
Conditions
Brief summary
This study seeks to evaluate the clinical performance of two daily disposable contact lenses.
Interventions
daily disposable contact lens
daily disposable contact lens
Sponsors
Study design
Eligibility
Inclusion criteria
* Be between 21 and 39 years of age. * Signed Written Informed Consent and Investigator to record this on Case Report Form (CRF) in appropriate space. * Be existing (i.e. successfully worn for 1-month prior to the study) soft contact lens wearers (no extended wear in the last 3 months, but silicone hydrogels in daily wear are allowed). * Require a visual correction in both eyes (monovision allowed but no monofit). * Have a contact lens spherical distance requirement between -1.00D and -6.00D in both eyes. * Astigmatism of 1.00D or less in both eyes. * Be able to wear the lens powers available for this study. * Be correctable to a visual acuity of 20/30 or better in each eye. * Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: * No amblyopia. * No evidence of lid abnormality or infection. * No conjunctival abnormality or infection. * No clinically significant slit lamp findings (i.e. edema, staining, scarring, vascularisation, infiltrates or abnormal opacities). * No other active ocular disease.
Exclusion criteria
* Requires concurrent ocular medication. * Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear. * Clinically significant (Grade 3 or 4) corneal edema, corneal vascularisation, corneal staining, tarsal abnormalities, bulbar injection or any other abnormality of the cornea that would contraindicate contact lens wear. * Diabetic. * Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV). * Extended lens wear in last 3 months. * PMMA or RGP lens wear in the previous 8 weeks. * Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrollment for this study. * Abnormal lacrimal secretions. * Pre-existing ocular irritation that would preclude contact lens fitting. * Keratoconus or other corneal irregularity. * Pregnancy, lactating or planning a pregnancy at the time of enrollment. * Participation in any concurrent clinical trial or in last 60 days.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Lens Comfort | 1-week follow-up | Lens comfort was evaluated via the subjective question: How comfortable did your eyes feel at the end of the day when wearing the contact lenses you were provided? (excellent/very good=5...very good=3...Poor=0) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comfort Throughout the Whole Day | 1-week follow-up | Comfort throughout the day was evaluated via subjective question: Comfort throughout the whole day and is reported as an aggregate of Agree Strongly and Agree Somewhat. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Comfort While Working on Computer | 1-week-follow-up | Comfort throughout the day was evaluated via subjective question: Comfort while working on computer and is reported as an aggregate of Agree Strongly and Agree Somewhat. |
Countries
Singapore
Participant flow
Recruitment details
There were 50 subjects enrolled in this single site study, located at Singapore University.
Pre-assignment details
There were 50 patients enrolled and randomized, and 50 patients completed the study.
Participants by arm
| Arm | Count |
|---|---|
| Overall Total number of completed participants are included in baseline measurements. | 50 |
| Total | 50 |
Baseline characteristics
| Characteristic | Overall |
|---|---|
| Age, Continuous | 25.0 years STANDARD_DEVIATION 4.8 |
| Sex: Female, Male Female | 31 Participants |
| Sex: Female, Male Male | 19 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk |
|---|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — | — / — |
| other Total, other adverse events | 0 / 12 | 0 / 13 | 0 / 13 | 0 / 12 |
| serious Total, serious adverse events | 0 / 12 | 0 / 13 | 0 / 13 | 0 / 12 |
Outcome results
Lens Comfort
Lens comfort was evaluated via the subjective question: How comfortable did your eyes feel at the end of the day when wearing the contact lenses you were provided? (excellent/very good=5...very good=3...Poor=0)
Time frame: 1-week follow-up
Population: Subjects analyzed were those who were enrolled, randomized, and completed the study.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Etafilcon A | Lens Comfort | 3.08 units on a scale | Standard Deviation 0.98 |
| Ocufilcon D | Lens Comfort | 3.00 units on a scale | Standard Deviation 1.15 |
Comfort Throughout the Whole Day
Comfort throughout the day was evaluated via subjective question: Comfort throughout the whole day and is reported as an aggregate of Agree Strongly and Agree Somewhat.
Time frame: 1-week follow-up
Population: Subjects analyzed were those enrolled, randomized, and completed the study.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Etafilcon A | Comfort Throughout the Whole Day | 39.2 percentage of participants |
| Ocufilcon D | Comfort Throughout the Whole Day | 36.7 percentage of participants |
Comfort While Working on Computer
Comfort throughout the day was evaluated via subjective question: Comfort while working on computer and is reported as an aggregate of Agree Strongly and Agree Somewhat.
Time frame: 1-week-follow-up
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Etafilcon A | Comfort While Working on Computer | 47.0 percentage of participants |
| Ocufilcon D | Comfort While Working on Computer | 42.9 percentage of participants |